India to Guatemala: Tofacitinib Export Trade Route

The India to Guatemala Tofacitinib corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $168.7K USD. The route is dominated by CROIENT PHARMA PRIVATE LIMITED, which alone accounts for roughly 92% of all export value, reflecting the consolidated nature of India's tofacitinib manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $24.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with tofacitinib's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 11.4%, placing it at rank #18 among India's top tofacitinib export destinations globally.

On the import side, key buyers of Indian tofacitinib in Guatemala include VMG HEALTHCARE PRODUCTS GUATEMALA S, BALAXI HEALTHCARE GUATEMALA, S.A.. VMG HEALTHCARE PRODUCTS GUATEMALA S is the single largest importer with 3 shipments valued at $155.3K USD.

India's tofacitinib exports to Guatemala are driven primarily by a handful of large-scale manufacturers. CROIENT PHARMA PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Guatemala benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CROIENT PHARMA PRIVATE LIMITED, BALAXI PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $24.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as tofacitinib tablets 5mg bt no. etn5b13 mfg dt.02/25 exp dt. 01/27 and tofacitinib tablets 5 mg (gstin-05aaccu1667l1z4/tax inv no.ub/2363) (each film coated tablet contains: tofacitinib citra, suggesting that buyers in Guatemala tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, VMG HEALTHCARE PRODUCTS GUATEMALA S is the largest importer with 3 shipments worth $155.3K USD — representing 92% of all tofacitinib imports from India on this route.